Cargando…

Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis()()

BACKGROUND: Psoriasis is a chronic systemic inflammatory disease frequently associated with serious comorbidities. OBJECTIVES: To investigate the systemic inflammatory burden in psoriasis and to assess the correlation between traditional and novel inflammatory markers and the severity of the disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirin, Mumtaz Cem, Korkmaz, Selma, Erturan, Ijlal, Filiz, Basak, Aridogan, Buket Cicioglu, Cetin, Emel Sesli, Yildirim, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562997/
https://www.ncbi.nlm.nih.gov/pubmed/32711928
http://dx.doi.org/10.1016/j.abd.2020.02.008
_version_ 1783595392427884544
author Sirin, Mumtaz Cem
Korkmaz, Selma
Erturan, Ijlal
Filiz, Basak
Aridogan, Buket Cicioglu
Cetin, Emel Sesli
Yildirim, Mehmet
author_facet Sirin, Mumtaz Cem
Korkmaz, Selma
Erturan, Ijlal
Filiz, Basak
Aridogan, Buket Cicioglu
Cetin, Emel Sesli
Yildirim, Mehmet
author_sort Sirin, Mumtaz Cem
collection PubMed
description BACKGROUND: Psoriasis is a chronic systemic inflammatory disease frequently associated with serious comorbidities. OBJECTIVES: To investigate the systemic inflammatory burden in psoriasis and to assess the correlation between traditional and novel inflammatory markers and the severity of the disease. METHODS: This cross-sectional study was conducted on 60 patients with psoriasis vulgaris and 50 healthy volunteers. Data including demographics, Psoriasis Area and Severity Index scores, and laboratory results were analyzed and compared. RESULTS: Compared with the control group, the psoriatic patients had significantly higher high sensitive C-reactive protein, serum amyloid A, erythrocyte sedimentation rate, leukocyte, neutrophil, neutrophil-to-lymphocyte ratio, monocyte to high density lipoprotein (HDL) cholesterol ratio, and aspartate aminotransferase levels, and significantly lower HDL cholesterol levels (p < 0.05). No significant difference was found in procalcitonin, lymphocyte, monocyte, hemoglobin, red blood cell distribution width, platelet, mean platelet volume, platelet distribution width, lymphocyte-to-monocyte ratio, anti-cyclic citrullinated peptide, glucose, alanine aminotransaminase, blood urea nitrogen, creatinine, triglyceride, total cholesterol, and LDL cholesterol levels between the two groups (p > 0.05). The Psoriasis Area and Severity Index score was positively correlated with high-sensitivity C-reactive protein, serum amyloid A, and monocyte to HDL cholesterol ratio, and negatively correlated with lymphocyte-to-monocyte ratio (p < 0.05). STUDY LIMITATIONS: This was a single-center study with relatively limited numbers of patients and controls. CONCLUSIONS: The data show that high sensitivity C-reactive protein, serum amyloid A, erythrocyte sedimentation rate, neutrophil-to-lymphocyte ratio, and monocyte to HDL cholesterol ratio can be used as markers of systemic inflammation in patients with psoriasis. Moreover, high sensitivity C-reactive protein, serum amyloid A, monocyte to HDL cholesterol ratio and lymphocyte-to-monocyte ratio are closely related to the Psoriasis Area and Severity Index score, and they may be regarded as objective indicators in determining the disease severity.
format Online
Article
Text
id pubmed-7562997
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-75629972020-10-20 Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis()() Sirin, Mumtaz Cem Korkmaz, Selma Erturan, Ijlal Filiz, Basak Aridogan, Buket Cicioglu Cetin, Emel Sesli Yildirim, Mehmet An Bras Dermatol Investigation BACKGROUND: Psoriasis is a chronic systemic inflammatory disease frequently associated with serious comorbidities. OBJECTIVES: To investigate the systemic inflammatory burden in psoriasis and to assess the correlation between traditional and novel inflammatory markers and the severity of the disease. METHODS: This cross-sectional study was conducted on 60 patients with psoriasis vulgaris and 50 healthy volunteers. Data including demographics, Psoriasis Area and Severity Index scores, and laboratory results were analyzed and compared. RESULTS: Compared with the control group, the psoriatic patients had significantly higher high sensitive C-reactive protein, serum amyloid A, erythrocyte sedimentation rate, leukocyte, neutrophil, neutrophil-to-lymphocyte ratio, monocyte to high density lipoprotein (HDL) cholesterol ratio, and aspartate aminotransferase levels, and significantly lower HDL cholesterol levels (p < 0.05). No significant difference was found in procalcitonin, lymphocyte, monocyte, hemoglobin, red blood cell distribution width, platelet, mean platelet volume, platelet distribution width, lymphocyte-to-monocyte ratio, anti-cyclic citrullinated peptide, glucose, alanine aminotransaminase, blood urea nitrogen, creatinine, triglyceride, total cholesterol, and LDL cholesterol levels between the two groups (p > 0.05). The Psoriasis Area and Severity Index score was positively correlated with high-sensitivity C-reactive protein, serum amyloid A, and monocyte to HDL cholesterol ratio, and negatively correlated with lymphocyte-to-monocyte ratio (p < 0.05). STUDY LIMITATIONS: This was a single-center study with relatively limited numbers of patients and controls. CONCLUSIONS: The data show that high sensitivity C-reactive protein, serum amyloid A, erythrocyte sedimentation rate, neutrophil-to-lymphocyte ratio, and monocyte to HDL cholesterol ratio can be used as markers of systemic inflammation in patients with psoriasis. Moreover, high sensitivity C-reactive protein, serum amyloid A, monocyte to HDL cholesterol ratio and lymphocyte-to-monocyte ratio are closely related to the Psoriasis Area and Severity Index score, and they may be regarded as objective indicators in determining the disease severity. Sociedade Brasileira de Dermatologia 2020 2020-07-12 /pmc/articles/PMC7562997/ /pubmed/32711928 http://dx.doi.org/10.1016/j.abd.2020.02.008 Text en © 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Investigation
Sirin, Mumtaz Cem
Korkmaz, Selma
Erturan, Ijlal
Filiz, Basak
Aridogan, Buket Cicioglu
Cetin, Emel Sesli
Yildirim, Mehmet
Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis()()
title Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis()()
title_full Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis()()
title_fullStr Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis()()
title_full_unstemmed Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis()()
title_short Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis()()
title_sort evaluation of monocyte to hdl cholesterol ratio and other inflammatory markers in patients with psoriasis()()
topic Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562997/
https://www.ncbi.nlm.nih.gov/pubmed/32711928
http://dx.doi.org/10.1016/j.abd.2020.02.008
work_keys_str_mv AT sirinmumtazcem evaluationofmonocytetohdlcholesterolratioandotherinflammatorymarkersinpatientswithpsoriasis
AT korkmazselma evaluationofmonocytetohdlcholesterolratioandotherinflammatorymarkersinpatientswithpsoriasis
AT erturanijlal evaluationofmonocytetohdlcholesterolratioandotherinflammatorymarkersinpatientswithpsoriasis
AT filizbasak evaluationofmonocytetohdlcholesterolratioandotherinflammatorymarkersinpatientswithpsoriasis
AT aridoganbuketcicioglu evaluationofmonocytetohdlcholesterolratioandotherinflammatorymarkersinpatientswithpsoriasis
AT cetinemelsesli evaluationofmonocytetohdlcholesterolratioandotherinflammatorymarkersinpatientswithpsoriasis
AT yildirimmehmet evaluationofmonocytetohdlcholesterolratioandotherinflammatorymarkersinpatientswithpsoriasis